"TXA Increasingly Used in Shoulder Surgery To Reduce Transfusion Risk and Complications"
Shawn Anthony, MD, MBA, assistant professor of orthopaedics at the Icahn School of Medicine at Mount Sinai presented at the 2018 AAOS meeting. He shared key findings of his study, "Rates of total shoulder arthroplasty are increasing, especially with an aging population. Blood loss requiring transfusion is less common than in total hip or knee replacements but still required in some patients. Tranexamic acid (TXA) is increasingly used to reduce blood loss in lower extremity arthroplasty but limited data exists for its effectiveness and safety in patients undergoing shoulder arthroplasty. We aimed to utilize national data to assess frequency of use and effectiveness of TXA in shoulder arthroplasty patients."
- Shawn Anthony, MD, MBA, Assistant Professor, Orthopaedics, Icahn School of Medicine at Mount Sinai